F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.
Posted inChemotherapy Cyberattacks and Hackers Cyberwarfare and Defense Doctors Drugs (Pharmaceuticals) Drugstores Finances Health and Human Services Department Health Insurance and Managed Care Hospitals Medicare Politics and Government Schumer, Charles E United States Politics and Government
Cyberattack Wreaks Havoc on Health Care Billing
The hack shut down the nation’s biggest health care payment system, causing financial chaos affecting a broad spectrum ranging from large hospitals to single-doctor practices.
Posted inBrain Clinical Trials Depression (Mental) Drug Abuse and Traffic Drug Enforcement Administration Drugs (Pharmaceuticals) Food and Drug Administration Heart Mental Health and Disorders Opioids and Opiates Pain-Relieving Drugs Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Research Therapy and Rehabilitation
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.
Posted inBrain Clinical Trials Depression (Mental) Drug Abuse and Traffic Drug Enforcement Administration Drugs (Pharmaceuticals) Food and Drug Administration Heart Mental Health and Disorders Opioids and Opiates Pain-Relieving Drugs Post-Traumatic Stress Disorder Psychedelic and Hallucinogenic Drugs Research Therapy and Rehabilitation
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.